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Abstract: With the use of stable isotopes, this study aimed to compare the bioavailability 
of active absorbable algal calcium (AAACa), obtained from oyster shell powder heated to a 
high temperature, with an additional heated seaweed component (Heated Algal Ingredient, 
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HAI), with that of calcium carbonate. In 10 postmenopausal women volunteers aged 59 to 
77 years (mean ± S.D., 67 ± 5.3), the fractional calcium absorption of AAACa and CaCO3 
was measured by a dual stable isotope method. 
44Ca-enriched CaCO3 and AAACa were 
administered in all subjects one month apart. After a fixed-menu breakfast and pre-test 
urine collection (Urine 0), 
42Ca-enriched CaCl2 was intravenously injected, followed by 
oral administration of 
44Ca-enriched CaCO3 without carrier 15 minutes later, and complete 
urine collection for the next 24 hours (Urine 24). The fractional calcium absorption was 
calculated as the ratio of Augmentation of 
44Ca from Urine 0 to Urine 24/ augmentation of 
42Ca from Urine 0 to Urine 24. Differences and changes of 
44Ca and 
42Ca were corrected by 
comparing each with 
43Ca. Fractional absorption of AAACa (mean ± S.D., 23.1 ± 6.4), was 
distinctly and significantly higher than that of CaCO3 (14.7 ± 6.4; p = 0.0060 by paired t-
test). The mean fractional absorption was approximately 1.57-times higher for AAACa 
than for CaCO3. The serum 25(OH) vitamin D level was low (mean ± S.D., 14.2 ± 4.95 
ng/ml), as is common in this age group in Japan. Among the parameters of the bone and 
mineral metabolism measured, none displayed a significant correlation with the fractional 
absorption of CaCO3 and AAACa. Higher fractional absorption of AAACa compared with 
CaCO3 supports previous reports on the more beneficial effect of AAACa than CaCO3  
for osteoporosis. 
Keywords: active absorbable algal calcium (AAACa); calcium carbonate; dual stable Ca 
isotope method; fractional absorption (FA); parathyroid hormone (PTH) 
 
1. Introduction  
Active absorbable algal calcium (AAACa) prepared from heated oyster shell and seaweed is a 
unique calcium supplement with high bioavailability, with a characteristic lamellar crystalline structure 
quite unlike that of calcium oxide and calcium carbonate (CaCO3) [1]. In the Katsuragi Calcium study, 
a prospective, randomized, double blind and placebo-controlled study compared the effect of AAACa 
on osteoporosis with that of CaCO3 in hospitalized women with a mean age of 80 years. It was found 
that AAACa alone increased spinal bone mineral density significantly over the level in subjects given a 
placebo, whereas CaCO3 did not [2,3]. Fracture occurrence over the two year test period from among 
58 subjects was 0 of 5 in the AAACa Group, 2 of 7 in the CaCO3 Group and 3 of 5 in the Placebo 
Group, on evaluation of all X-rays available at the beginning and end of the test period. The AAACa 
Group exhibited a significantly lower rate of fracture occurrence than the  placebo group, but the 
CaCO3  Group  showed no significant difference from placebo group.  Serum  parathyroid hormone 
(PTH) was also suppressed more efficiently by AAACa than CaCO3. 
Despite all these indirect lines of evidence indicating a high bioavailability of AAACa, a direct 
absorption test by a dual isotope method has not been conducted to date. We have therefore attempted 
to measure the fractional absorption of AAACa by using the dual stable-isotope method [4,5]  to Nutrients 2010, 2                                       
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compare it with CaCO3  in  subjects in the age group most likely to need effective calcium 
supplementation to maintain their bone health: postmenopausal women. 
2. Experimental Section  
2.1. Subjects 
Ten postmenopausal women between 59 and 77 years of age (mean ± SD, 67 ± 5.3 years) leading a 
normal healthy daily life without any known disease possibly affecting bone and mineral metabolism 
volunteered to participate as test subjects in the present study by providing written consent (Table 1). One 
subject, shown in parenthesis in Tables 1 and 2, was dropped from analysis because of a measured 
fractional absorption (FA) value of 0% on giving CaCO3. The Institutional Review Board of the Fujii 
Medical Clinic approved the study. 
Table 1. Background of the test subjects. 
No.  Age  Years 
after 
menopause 
Heigh
t 
(cm) 
Weigh
t 
(kg) 
Systolic blood pressure 
(mmHg) 
Diastolic blood pressure 
(mmHg) 
1  68  19  154  54  138  80 
2  72  23  147  50  142  62 
3  65  15  157  63  148  70 
4  65  13  148  43  125  70 
(5) *  (59)  (9)  (153)  (60)  (133)  (88) 
6  59  8  152  58  152  85 
7  65  13  151  56  150  85 
8  77  28  150  48  142  80 
9  64  15  145  50  140  90 
10  71  19  148  48  122  70 
Mea
n 
67  17  150  52  139  76 
SD  5.3  6.0  3.7  6.1  10.4  9.3 
* Case No. 5 was not included in the statistical analysis. 
 
2.2. Background Data of the Test Subjects 
In order to assess the metabolic background of the test subjects, serum Ca, P, albumin, creatinine, 
BUN, 25(OH)vitamin D, intact parathyroid hormone (PTH), bone specific alkaline phosphatase (BAP), 
urinary N-terminal type I collagen fragments (NTx) and urinary calcium/ creatinine ratio   
(UCa/ Cr) were measured prior to the test. The laboratory tests related to bone and calcium metabolism 
gave results approximately within the normal range, as shown in Table 2, except for one subject, who 
had a serum 25(OH) vitamin D level in the insufficiency range (7.6 ng/mL). This subject was without 
symptoms and signs of vitamin D insufficiency such as hypocalcemia, hypophosphatemia, high 
alkaline phosphatase, muscle weakness and bone pain. 
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Table 2. Parameters of mineral and bone metabolism of the test subjects. 
No. 
Serum 
Ca 
Serum 
P 
Serum 
albumin 
Serum 
creatinine 
BUN  25(OH) 
vitamin D 
Intact 
PTH 
BAP  Urine 
NTx/Cr 
Urine 
Ca/Cr 
mg/dL  mg/dL   g/dL  mg/dL  mg/dL  ng/dL  pg/dL  U/L   nMBCE/
mMCr 
mg/mg 
1  9.7  3.9  4.4  0.83  11.0  16.8  48  15.2  32.2  0.03 
2  9.5  4.5  4.0  0.80  21.9  16.9  31  15.1  16.0  0.06 
3  9.7  3.1  4.6  0.71  12.1  11.6  40  35.8  31.1  0.45 
4  10.3  3.5  5.1  0.49  12.5  11.7  44  32.4  35.9  0.36 
5 *  (9.5)  (3.4)  (4.5)  (0.74)  (14.2)  (21.8)  (61)  (21.6)  (29.0)  (0.08) 
6  9.8  3.5  4.7  0.74  17.8  15.4  44  19.1  23.0  0.12 
7  9.3  4.4  4.4  0.60  17.8  24.7  42  17.0  42.2  0.22 
8  9.9  2.9  4.6  0.59  13.5  7.6  50  34.9  34.5  0.17 
9  9.8  3.7  4.4  0.74  13.7  12.7  34  27.5  16.3  0.20 
10  9.5  3.3  4.2  0.54  13.6  10.8  34  45.9  21.9  0.30 
Mean  9.7  3.6  4.5  0.67  14.9  14.2  41  27.0  28.1  0.21 
SD  0.29  0.55  0.31  0.119  3.53  4.95  6.59  11.02  9.20  0.138 
Ca: calcium;  P:  phosphorus;  BUN: Blood urea nitrogen;  PTH: parathyroid hormone;  BAP: Bone specific  alkaline 
phosphatase; BCE: Bone collagen equivalent. 
* Case No. 5 was not included in the statistical analysis 
 
2.3. Materials 
The first part of the test was performed on March 9, 2009, using 
44Ca-enriched CaCO3 for oral load 
and 
42Ca in the form of CaCl2, for intravenous injection (Table 3). On April 13, 2009, after one month, 
exactly the same procedure was repeated on the same test subjects, except for the use of 
44Ca-enriched 
AAACa in the place of CaCO3 to ensure the stable isotope constituent of the body reached equilibrium. 
Intrinsic labeling is no doubt ideal, but it is impossible to label the shell of oysters abiding in the ocean, 
so an extrinsic labeling was adopted as the best substitute for it. The material for AAACa was obtained 
by heating oyster shell to 1,000 
oC, resulting mostly in CaO powder after losing much of the organic 
components. To 5,082 mg of this CaO powder, 450.4 mg CaO Ca fraction was added that consisted of 
95.9 ± 0.3% 
44Ca supplied by TRACE SCIENCES INTERNATIONAL (Ontario, Canada), and was 
thoroughly mixed in a melting pot. Aqueous solution of a small amount of algal component was pre-
heated at a high temperature in a manner similar to the oyster shell to start a chemical reaction lasting 
for about 10 minutes. After sufficient stirring, it was divided into small portions for actual use and 
preserved in vacuum. The final product mostly consisted of Ca(OH)2. Nutrients 2010, 2                                       
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CaCO3 labeled with 
44Ca was also obtained from the same source (the Ca fraction consisting of 
95.9 ± 0.3% 
44Ca). To 781.6 mg of this material,  9,075 mg CaCO3 (Japanese Pharmacopeia) was 
added, thoroughly mixed, and divided into small proportions and stored.  
AAACa particle mean size was 5.8 microns; maximum size was 75 microns and CaCO3 particle 
size ranged from 10 to 20 microns. As these values are based on different occasions of measurements 
they may not be directly comparable, but appears to lie over a similar range. If anything, a larger size is 
compatible with slower absorption.  
For two subjects, part of the first urine sample was lost; in these cases, both parts of the test were 
repeated on July 30 and August 27, and the data from the uneventfully performed second set of tests 
were used to replace those of the first set.  
The safety of the intravenous injection of CaCl2 was verified before the study by the absence of any 
signs of toxicity such as chills, fever, neuromuscular irritability,  skin eruptions, disturbance of 
consciousness, etc. 
Table 3. Amount of isotope Ca (mg) per subject in 1 study. 
Isotope 
Oral  IV 
CaX  CaY 
Total 
Supplied  Added  Total  Supplied  Added  Total 
42Ca  0.01  1.79  1.80  0.00  1.79  1.79  3.192 
43Ca  0.01  0.39  0.40  0.00  0.39  0.39  0.0037 
44Ca  25.38  5.52  30.90  25.38  5.53  30.91  0.0334 
 
The contents of Ca isotopes in the material used for the preparation of CaX and CaY on arrival from 
the supplier (Supplied), their contents in the material added to prepare samples for administration 
(Added) and the final total (Total) are indicated in Table 3. 
A total of approximately 300 mg of Ca containing approximately 30 mg 
44Ca isotope (25 + 5) was 
orally administered to each subject and about 3 mg 
42Ca isotope was injected before the study and no 
symptoms and signs of toxicity were reported.  
2.4. Test Procedure 
After taking a fixed menu breakfast consisting of fruit juice, toast, eggs and coffee, a pre-test urine 
sample was collected (Urine 0) and 
44Ca-enriched CaCO3 was orally administered followed by the 
intravenous injection of 
42Ca-enriched CaCl2 15 minutes later. A complete collection of 24 h urine 
followed (Urine 24). After one month to ensure clearance of the enriched isotope, exactly the same 
procedure, except for the use of
 44Ca-enriched AAACa instead of 
44Ca-enriched CaCO3, was repeated.  
2.4.1. Measurement of the Stable Isotope 
Sample preparation for isotope enrichment measurement was conducted according to the method of 
Patterson et al. [6]. By using the inductively coupled plasma mass spectrometry (ICP-MS, Agilent 
7500 cs, Agilent Technologies, Inc., Tokyo), 
42Ca, 
43Ca, 
43Ca and other measurable stable Ca isotopes 
were measured in both Urine 0 and Urine 24. Utilizing 
43Ca as an internal standard of the stable Ca Nutrients 2010, 2                                       
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isotopes, the ratio of each stable Ca isotope to 
43Ca was calculated. The increase of the 
42Ca/
43Ca and 
44Ca/
43Ca in Urine 24 above the pretest natural abundance level for each test subject over the 
corresponding value in Urine 0 was then obtained. By dividing the ratio of the actual amount of the 
enrichment of 
44Ca by the corresponding amount of the enrichment of 
42Ca from Urine 0 to Urine 24, 
the FA of the 
44Ca-enriched material was obtained; for CaCO3 in the first part of the test and AAACa 
in the second part (Table 3). 
2.5. Statistical Analysis 
The Excel Statistical Package was used to compare the FA of CaCO3 and AAACa by paired t-test. 
A correlation matrix among the FA data, age and parameters of bone and mineral metabolism was 
constructed and evaluated by the Spearman method in view of the inclusion of variables with uncertain 
distribution. The p values < 0.05 were considered significant.  
3. Results and Discussion  
As shown in Table 4, the mean Fractional absorption (FA) of AAACa, 23.1 ± 6.4%, was 1.57-
times higher  than  the  corresponding value of CaCO3, 14.7 ± 6.4%, with a significant difference at   
p = 0.0060 determined using paired t-test. 
Table 4. Fractional absorption (FA) of CaCO3 and AAACa by dual stable isotope method. 
Subject  FA CaCO3  FA AAACa 
1  7.5  21.1 
2  20.0  29.7 
3  21.9  34.7 
4  19.6  20.4 
(5) *  (0.0)  (18.8) 
6  6.1  22.7 
7  14.3  24.9 
8  11.7  11.9 
9  8.7  22.1 
10  22.2  20.4 
Mean  14.7  23.1 
SD  6.4  6.4 
Paired comparison between FA CaCO3 and FA AAACa 
p = 0.0060, t = 3.708 (paired t-Test) 
* Subject 5 was not included in the statistical analysis. 
 
According to the evaluation by means of the correlation coefficient matrix (Spearman) (Table 5) 
among  the  parameters of bone and mineral metabolism summarized in Table 2, no significant 
correlation was found between the FA of either calcium carbonate or AAACa and each parameter. In 
the subject with the lowest serum 25(OH) vitamin D of 7.6 ng/mL, the FA of CaCO3 value was 
medium in the group, i.e., 11.7%, fifth from the lowest, and the FA of AAACa, 11.9%, was the lowest 
in the group. Nutrients 2010, 2                                       
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Until the advent of the dual isotope method, the true FA of calcium was extremely difficult to 
measure due to the complex behavior of calcium in living organisms, such as the rapid exchange 
through multiple Ca pools and various pathways of exit and reentrance [7,8]. Utilizing the presence of 
multiple stable isotopes in nature, the dual stable isotope method was developed to circumvent this 
complexity, and it is the only method of directly measuring the fractional intestinal Ca absorption. 
Abrams and coworkers as well as other investigators [12-23] have used this method extensively to 
estimate calcium absorption, establishing it as the gold standard for calcium absorption. Since calcium 
absorption is influenced by age and the state of bone, as well as mineral metabolism, a correlation 
matrix was constructed and evaluated by Spearman’s method (Table 5). None of the metabolic 
parameters tested exhibited significant correlation with FA of the calcium compounds. Absence of 
significant correlation between FA of calcium compound and age was expected because of the narrow 
age range of this group. 
The FA of Ca compounds obtained in this study of postmenopausal women, with a mean age of 66 
years and with a tendency of low 25(OH) vitamin D, appears to be much lower than those observed in 
children and younger subjects:  FA; 54.8–63.1%  [21], 58.2–64.3%  [22],  and  also  younger 
postmenopausal women with mean age of 56: FA; 34.6–39.1% [23]. In healthy volunteers between 25 
to 45 years much lower values, yet still higher than the results in the present study, were reported: FA; 
26–31% [24]. The reduced FA in the current study subjects could also be due to reduced estrogen level 
after menopause. FA is, thus, markedly influenced by age. The age range of the test subjects was quite 
narrow in this group of subjects, unsuitable for the assessment of the age-FA correlation. Statistically, 
the tendency of age-FA correlation was non-significant. 
Table 5.  Spearman’s correlation matrix and correlation coefficients among fractional 
absorption (FA) and parameters of bone and mineral metabolism. 
  FA 
CaCO3 
FA 
AAACa 
Age  SCa  SP  Salb  Cre  BUN  25D  PTH  BAP  UNTx  UCa/Cr 
FA 
CaCO3 
1.0000  0.1423  0.4238  −0.388
2 
−0.192
5 
−0.340
5 
−0.485
4 
−0.0335  −0.3167  −0.5630  −0.4833  −0.1333  0.6333 
FA 
AAACa 
  1.0000  −0.349
0 
−0.529
7 
0.4328  −0.213
7 
0.5042  0.3445  0.5690  −0.5232  −0.3766  −0.2762  0.0418 
SCa: serum calcium;  SP: serum phosphate;  Salb: serum albumin;  Cre: creatinine;  BUN: blood urea nitrogen;  25D: 
25(OH)vitaminD; PTH: parathyroid hormone; BAP: bone specific alkaline phosphatase; UNtx: urine N-terminal type I 
collagen fragments; UCa/Cr: urinary Ca/creatinine ratio 
 
Although these subjects are reasonably homogeneous and apparently free of any comorbidity, which 
could potentially influence the test results, the present study is limited by the small number of test 
subjects. Unlike similar studies conducted in this field in the past, post-menopausal women – who need 
calcium supplementation most because of high risk of osteoporosis – were asked to participate. A 
rather low intra-group variation was encouraging, and a clear-cut difference in FA between the two test 
materials may also add to the credibility of the conclusion. 
It is possible that  the difference in molecular weight and  physicochemical  properties of the  
44Ca-enriched CaCO3 and AAACa, mostly consisting of Ca(OH)2 as the result of oxidation of CaCO3 Nutrients 2010, 2                                       
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obtained from oyster shell, cannot be completely ruled out. The similar molecular size and comparable 
particle size actually measured as 5.8 to 75 for AAACa and 10 to 20 for CaCO3 and this is a limitation 
of the result but should not have affected the primary outcome. In view of the similar molecular size 
and physicochemical properties between CaCO3 and AAACa, both much smaller than organic Ca salts, 
however, confounding effect exerted on the calculation of the absorptive rate is rather unlikely and the 
conclusion of difference in the absorption rate between the two compounds should be   
reasonably supported.  
4. Conclusions  
This study aimed to compare the bioavailability of active absorbable algal calcium (AAACa), oyster 
shell powder heated to a high temperature, with an additional heated seaweed component (Heated 
Algal Ingredient, HAI), with that of calcium carbonate. The Fractional absorption of AAACa, (mean ± 
S.D.;  23.1  ±  6.4) was distinctly  and significantly higher than that of CaCO3  (14.7  ±  6.4;  
p = 0.0060 by paired t-test). The mean was approximately 1.57-times higher for AAACa than CaCO3. 
Higher fractional absorption of AAACa compared with CaCO3 supports previous reports on the more 
beneficial effect of AAACa than CaCO3 on osteoporosis. 
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